|
|
 |
Childhood Cancer
Clinical Research
The goal of clinical research in CFRI’s Childhood Cancer research cluster is to coordinate and provide leadership for the development of clinical Phase I and Phase II treatment protocols, utilizing agents identified by the basic / translational research component of the program.
Dr. Paul Rogers, Head of the Hematology, Oncology and Bone Marrow Transplant Program at BC Children’s Hospital; Clinical Professor and Division Head for the UBC Department of Pediatrics, leads the clinical research team. He is an experienced clinical investigator through the Children’s Oncology Group (COG) and oversees the clinical research activities of the Pediatric Oncology Program. Dr. Rogers is the co-chair of the B.C. Pediatric Oncology Network.
The program is also a leader in the Canadian Bone Marrow Transplantation (BMT) Group, with Dr. Schultz serving as Chair of the Group’s Clinical Trials Network. He is also the Chair-elect of the international Pediatric Bone Marrow Transplantation Consortium (PBMTC), and his laboratory is a reference laboratory for both groups. He also chairs an international Phase III Trial in acute lymphoblastic leukemia (ALL).
Together, the Childhood Cancer research cluster and the Clinical Research Program are the designated Tumour Group for Pediatrics at BC Children’s Hospital, BC Cancer Agency and University of British Columbia. BC Children's and BC Cancer Agency are agencies of the Provincial Health Services Authority.
Dr. Rogers is collaborating with colleagues at BC Cancer Agency on a major study on cancer survivorship in children and adolescents. They are determining the long-term effects of cancer survival and the policy requirements of this population. Initially funded by Health Canada, the current phase of the research is funded by CIHR.
Dr. Rogers is in the early stages of a research partnership between CCRP and CFRI’s Nutrition & Metabolism research program, under the leadership of Dr. Sheila Innis, examining the relationship between nutrition and outcomes for oncology patients.
The program is also actively undertaking clinical research in the area of appropriate psychosocial supports for patients and survivors.
Researchers
|
« Back to Childhood Cancer page
|
Last updated:
08/27/2009
|
|
 |
|
